Healthcare | August 10, 2021
Merck launches New Pergoveris Pen for fertility treatment in India
A globally approved pen filled by mass technology provides a safer self- administration fertility solution
A globally approved pen filled by mass technology provides a safer self- administration fertility solution
Deal signed with AOP Orphan for US commercial rights
A veteran in cell therapy and oncology commercialisation
The drug is indicated for mild and transient episodes of heart block
It leverages Kite’s Chimeric Antigen Receptors and Appia Bio’s Allogeneic Cell Technology Platform to Develop Off-the-Shelf Cell Therapies
The product can be used by any lab that conducts NGS testing, making precision medicine accessible to all cancer patients
Founded in 2019, the start-up develops digital therapeutics, a therapeutic intervention from the convergence of biology and information technology
Partnership enables broad reach of cfDNA methylation blood tests for early cancer detection
Preclinical and early human data indicate BriLife may confer enhanced immunity against Delta variant
The company posted net profit of Rs.34.24 crores for the period ended June 30, 2020.
Subscribe To Our Newsletter & Stay Updated
